Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (5063)	9/10/1999 5:53:00 PM
From: Jibacoa	Read Replies (1) \| Respond to of 13094

JIM: And still another Biotech with a decent looking chart and some good news is IVX. Here is some of the news: MIAMI--(BUSINESS WIRE)--Sept. 9, 1999--IVAX Corporation (AMEX:IVX - news) today announced that its patented Easi-Breathe(TM) Breath-Activated inhalation device, developed by the company's Norton Healthcare Limited subsidiary headquartered in London, U.K., has been granted ``Millennium Product' status by the U.K.'s prestigious Design Council. The innovative inhaler has won two other coveted awards in the U.K. as well: the 1997 Prince of Wales Award for Innovation and the 1998 Royal Academy of Engineering's MacRobert Award. It seems to have some future in it,instead of the patient having to "time" pressing the gadget at inhalation time or using a "spacer" their gadget is triggered by the patient's inhalation. They also received FDA approval for a new generic drug. Bernard